Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2011. Upgrade now.
Date Value
March 31, 2024 11.73M
December 31, 2023 16.75M
September 30, 2023 12.16M
June 30, 2023 6.249M
March 31, 2023 6.722M
December 31, 2022 8.958M
September 30, 2022 4.903M
June 30, 2022 11.20M
March 31, 2022 1.122M
December 31, 2021 15.54M
September 30, 2021 7.835M
June 30, 2021 8.369M
March 31, 2021 1.345M
December 31, 2020 -0.0882M
September 30, 2020 6.729M
June 30, 2020 0.2401M
March 31, 2020 -4.908M
December 31, 2019 7.082M
September 30, 2019 18.95M
June 30, 2019 12.93M
March 31, 2019 9.462M
December 31, 2018 3.846M
September 30, 2018 33.29M
June 30, 2018 8.362M
March 31, 2018 12.28M
Date Value
December 31, 2017 11.28M
September 30, 2017 11.27M
June 30, 2017 8.945M
March 31, 2017 8.365M
December 31, 2016 -25.92M
September 30, 2016 13.77M
June 30, 2016 20.56M
March 31, 2016 55.07M
December 31, 2015 22.92M
September 30, 2015 17.61M
June 30, 2015 18.14M
March 31, 2015 36.29M
December 31, 2014 1.947M
September 30, 2014 16.31M
June 30, 2014 -252.96M
March 31, 2014 1.913B
December 31, 2013 28.19M
September 30, 2013 22.66M
June 30, 2013 32.91M
March 31, 2013 31.22M
December 31, 2012 27.93M
September 30, 2012 24.56M
June 30, 2012 20.10M
March 31, 2012 43.51M
December 31, 2011 53.01M

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

-4.908M
Minimum
Mar 2020
18.95M
Maximum
Sep 2019
7.691M
Average
7.459M
Median

Net Income (Quarterly) Benchmarks

Affimed NV -20.83M
InflaRx NV -10.49M
MorphoSys AG 51.98M
BioNTech SE -342.26M
Immatics NV -3.317M